C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2006
11/07/2006	US7132435 Syn-1H-indazole-3-carboxylic acid (4-{[2-(2,3-dihydro-benzo[b]thiophen-6-yloxy)-5-fluoro-pyridine-3-carbonyl]amino}-cyclohexyl)-amide; useful as cyclic nucleotide phosphodiesterase-4 ( PDE-4 ) inhibitor
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132427 Quinazolines and uses thereof
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006	US7132421 Antiproliferative agnets
11/07/2006	US7132414 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006116563A1 Vanilloid receptor ligands and their use in treatments
11/02/2006	WO2006116165A1 Chromane and chromene derivatives and uses thereof
11/02/2006	WO2006116157A2 Dipeptidyl peptidase-iv inhibitors
11/02/2006	WO2006115286A1 Piperidine derivatives, crystal, process for producing the same, and use as tachikinin receptor antagonists
11/02/2006	WO2006115247A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
11/02/2006	WO2006115245A1 4-ethynylisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115244A1 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115140A1 Preventive or remedy for bowel disease
11/02/2006	WO2006114706A1 Triazole derivatives as vasopressin antagonists
11/02/2006	WO2006114666A1 SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
11/02/2006	WO2006114575A1 Novel development accelerator-releasing couplers
11/02/2006	WO2006114415A2 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114221A1 Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
11/02/2006	WO2006114220A1 Herbicidally active phenylsulphonyl-urea
11/02/2006	WO2006114213A1 4-(pyridin-3-yl)-2-(pyridin-2-yl)-1,2-dihydro-3h-pyrazol-3-one derivatives as specific hif-prolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases
11/02/2006	WO2006099060A3 Process for the preparation of opioid modulators
11/02/2006	WO2006091428A3 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006089664A3 Heterocyclylamide-substituted imidazoles
11/02/2006	WO2006088921A3 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088919A3 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088837A3 Heterocyclic substituted piperazines with cxcr3 antagonist activity
11/02/2006	WO2006088836A3 Piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006084854A3 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/02/2006	WO2006074264A3 Preparation of ketone amides
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors
11/02/2006	WO2005103034A8 Novel piperidine substituted diaminothiazoles
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247440 Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
11/02/2006	US20060247439 Mchir antagonists
11/02/2006	US20060247437 Preparation of ketone amides
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247247 Pyrazole-amine compounds useful as kinase inhibitors
11/02/2006	US20060247243 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
11/02/2006	US20060247242 Pesticidal compositions
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247239 Melanin concentrating hormone antagonists
11/02/2006	US20060247227 Substituted piperidines as histamine h3 receptor ligands
11/02/2006	US20060247225 e.g. (1 alpha ,5 alpha ,6 alpha )-N-[3-(4-methyl-3-pentenyl)-3-azabicyclo[3.1.0]hex-6-yl]-2-hydroxy-2-cyclopentyl-2-(4-methoxy)phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
11/02/2006	US20060247224 Melanocortin receptor ligands
11/02/2006	US20060247217 Tricyclic protein kinase inhibitors
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060246023 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/02/2006	EP1717237A1 Anthranilamides, process for the production thereof, and pest controllers containing the same
11/02/2006	EP1717235A2 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006	EP1717234A1 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
11/02/2006	EP1717232A1 Phenylsulfonylureas with herbicidal activity
11/02/2006	EP1717231A1 Substituted azole compounds and thereof preparation and application
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717228A1 Sulfonylamino(thio)carbonylderivatives as herbicides or plant growth regulators
11/02/2006	EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717221A1 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716867A1 Preventives for migraine
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716143A1 Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006	EP1716137A1 Substituted quinoline compounds
11/02/2006	EP1716136A1 Pyridine benzimidazole sulfoxides of high purity
11/02/2006	EP1716135A1 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
11/02/2006	EP1716134A1 Amino heterocyclic modulators of chemokine receptor activity
11/02/2006	EP1716133A1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
11/02/2006	EP1716130A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006	EP1716126A1 Morpholine derivatives as norepinephrine reuptake inhibitors
11/02/2006	EP1716125A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
11/02/2006	EP1716123A1 Pyridazinone derivatives and their use as pde4 inhibitors
11/02/2006	EP1716118A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1539747B1 N-aroyl cyclic amines as orexin receptor antagonists
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1427740B1 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins rung
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1399117B1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
11/02/2006	EP1377278B1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
11/02/2006	EP1349535B1 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors

1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 1080